Posted by desolationrower on August 23, 2008, at 20:02:04
In reply to Re: Parnate trial » desolationrower, posted by SLS on August 23, 2008, at 6:32:20
I think the lack of benefit over other agents, plus antihistimines cause metabolic problems if used over time. They don't even promote good sleep. Quetiepine at low doses probably doesn't affect d2 and so has a low chance of the neuroleptic side effects, but that also means its got zero benefit (also probably not affecting 5ht2a). Still, higher doses do have that effect.
poster:desolationrower
thread:847722
URL: http://www.dr-bob.org/babble/20080822/msgs/847920.html